Japan is rapidly improving access to innovative medicines through recent policy changes, creating new opportunities for pharma companies to enter and grow in this evolving market. For those ready to act, it represents a strategic growth opportunity despite existing access gaps.
Loading transcript...
Related insights
You might also be interested in these insights.
English